Structure and function of the anaphylatoxins (original) (raw)

• Bjork J, Arfors K-E, Dahlen S-E, Hedqvist P (1981) In: Venge P, Lindborn A (eds) The inflammatory process. Chapter 6. Almqvist & Wiksell International, Stockholm, Sweden, p 103
  Google Scholar
• Bjork J, Hedqvist P, Arfors K-E (1982) Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes. Inflammation 6: 189
  PubMed Google Scholar
• Bodammer G, Vogt W (1970) Increase in vascular permeability of guinea pig skin induced by anaphylatoxin. Naunyn-Schmiedebergs Arch Pharmacol 266: 255
  PubMed Google Scholar
• Bokisch VA, Muller-Eberhard HJ (1970) Anaphylatoxin inactivator of human plasma; its isolation and characterization as a carboxypeptidase. J Clin Invest 49: 2427
  PubMed Google Scholar
• Caporale LH, Tippett PS, Erickson BW, Hugh TE (1980) The active site of C3a anaphylatoxin. J Biol Chem 255: 10758
  PubMed Google Scholar
• Chenoweth DE, Hugh TE (1978) Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 75: 3943
  PubMed Google Scholar
• Chenoweth DE, Hugh TE (1980) Binding, internalization and degradation of human C5a by human neutrophils. Fed Proc 39: 1049
  Google Scholar
• Chenoweth DE, Hugh TE (1980) Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol Immunol 17: 151
  PubMed Google Scholar
• Chenoweth DE, Erickson BW, Hugh TE (1979) Human C5a-related synthetic peptides as neutrophil chemotactic factors. Biochem Biophys Res Commun 86: 227
  PubMed Google Scholar
• Chenoweth DE, Rowe JG, Hugh TE (1979) A modified method for chemotaxis under agrose. J Immunol Methods 25: 337
  PubMed Google Scholar
• Chou PY, Fasman GD (1974) Prediction of protein conformation. Biochemistry 13: 222
  PubMed Google Scholar
• Clancy RM, Dahinden CA, Hugh TE (1984) Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl peptide or C5a is independent of phospholipase activation. Proc Natl Acad Sci USA 80: 7200
  Google Scholar
• Cochrane CG, Muller-Eberhard HJ (1968) The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med 127: 371
  PubMed Google Scholar
• Corbin NC, Hugh TE (1976) The primary structure of porcine C3a anaphylatoxin. J Immunol 117: 990
  PubMed Google Scholar
• Craddock PR, Hammerschmidt D, White JG, Dalmasso AP, Jacob HS (1977) Complement (C5a)induced granulocyte aggregation in vitro: a possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest 60: 260
  PubMed Google Scholar
• Dahinden CA, Fehr J, Hugh TE (1983) Role of cell surface contact on the kinetics of superoxide production by granulocytes. J Clin Invest 72: 113
  PubMed Google Scholar
• Damerau B, Zimmermann B, Wustefeld K, Czorniak K, Vogt W. (1983) Involvement of the N-terminus of hog C3a, C5a and C5ades Arg in their biological activities. Immunobiology 164: 229 (abstract)
  Google Scholar
• Daniele RP (1981) Immune complex injury of the lung. Am J Resp 124: 735
  Google Scholar
• Desai U, Kreutzer DL, Showell H, Arroyave CV, Ward PA (1979) Acute inflammatory pulmonary reactions induced by chemotactic factors. Am J Pathol 96: 71
  PubMed Google Scholar
• Fernandez HN, Hugh TE (1976) Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide portions of human C5a. J Immunol 117: 1688
  PubMed Google Scholar
• Fernandez HN, Hugh TE (1978) Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. I. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem 253: 6955
  PubMed Google Scholar
• Fernandez HN, Henson PM, Hugli TE (1978) Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluations of C3a and C5a leukotaxis in vivo and in vitro. J Immunol 120: 109
  PubMed Google Scholar
• Fey GH, Domdey H, Wiebauer K, Whitehead AS, Odink K (1983) Structure and expression of the C3 gene. Springer Seminars Immunopathol 6: 119
  Google Scholar
• Fey GH, Wiebauer K, Domdey H (in press) Amino acid sequences of mouse complement C3 derived from nucleotide sequences of cloned cDNA. Ann NY Acad Sci
• Friedberger E (1910) Weitere Untersuchungen über Eiweißanaphylaxie. IV. Mitteilung. Z Immunitätsforsch Exp Ther 4: 636
  Google Scholar
• Gerard C, Hugh TE (1980) Amino acid sequence of the anaphylatoxin from the fifth component of porcine complement. J Biol Chem 255: 4710
  PubMed Google Scholar
• Gerard C, Chenoweth DE, Hugh TE (1979) Molecular aspects of the serum chemotactic factors. J Reticuloendothel Soc 26: 711
  PubMed Google Scholar
• Gerard C, Chenoweth DE, Hugh TE (1981) Response of human neutrophils to C5a: A role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biological activity. J Immunol 127: 1978
  PubMed Google Scholar
• Glovsky MM, Hugh TE, Ishizaka T, Lichenstein LM, Erickson BW (1979) Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. J Clin Invest 64: 804
  PubMed Google Scholar
• Goetzl EJ, Austen KF (1974) Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. J Clin Invest 53: 591
  PubMed Google Scholar
• Goldstein IM, Feit F, Weissmann G (1975) Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis. J Immunol 114: 516
  PubMed Google Scholar
• Gorski JP, Hugh TE, Muller-Eberhard HJ (1981) Characterization of human C4a anaphylatoxins. J Biol Chem 256: 2707
  PubMed Google Scholar
• Hammerschmidt DE, Harris P, Wayland JH, Jacob IS (1978) Intravascular granulocyte (PMN) aggregation in live animals: a complement (C) mediated mechanism of ischemia. Blood 52 [Suppl 1] 125
  Google Scholar
• Hausman MS, Snyderman R, Mergenhagen SE (1972) Humoral mediators of chemotaxis of mononuclear leukocyte. J Infect Dis 125: 6
  Google Scholar
• Havemann K, Janoff A (Eds) (1978) Neutral proteases of human polymorphonuclear leukocytes. Urban and Schwarzenberg, Baltimore
  Google Scholar
• Henson PM, Zanolari B, Schwartzman NA, Hong SR (1978) Intracellular control of human neutrophil secretion. 1. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. J Immunol 121: 851
  PubMed Google Scholar
• Henson PM, McCarthy K, Larsen GL, Webster RO, Giclas PC, Dreisen RB, King TE, Shaw JD (1979) Complement fragments, alveolar macrophages and alveolitis. Am J Pathol 97: 93
  PubMed Google Scholar
• Hill JH, Ward PA (1969) C3 leukotactic factors produced by a tissue protease. J Exp Med 130: 505
  PubMed Google Scholar
• Huber R, Scholze H, Paques EP, Deisenhofer J (1980) Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppes-Seylers Z Physiol Chem 361: 1389
  Google Scholar
• Huey R, Bloor CM, Kawahara MS, Hugli TE (1983) Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and effects on pulmonary tissue. Am J Pathol 112: 48
  PubMed Google Scholar
• Hugh TE (1975) Human anaphylatoxin (C3a) from the third component of complement: Primary structure. J Biol Chem 250: 8293
  PubMed Google Scholar
• Hugh TE (1981) The complement anaphylatoxins. In: Hofstaetter T, Schorlemmer HU (aeds) Topics in allergology. Vol 68. Behring Institute Mitteilungen, Die Medizinische Verlagsgesellschaft mbH, Marburg, p 68
  Google Scholar
• Hugh TE (1981) The structural basis for anaphylatoxin in chemotactic functions of C3a and C5a. CRC Crit Rev Immunol I: 321–366
  Google Scholar
• Hugh TE (1982) Bioactive factors of the blood complement system. In: Bradshaw RA, Hill RL, Tang J (eds) Proteins in biology and medicine. Proceedings of P.R.C.-USA Conference in Shanghai, China, Academic Press, New York, pp 91–117
  Google Scholar
• Hugh TE (1983) Action of the anaphylatoxins on pulmonary tissues. In: Bostrom H, Youngsted N (eds) Theoretical and clinical aspects of allergic diseases, Scandia International Symposium (October 12–14, 1982). Almqvist & Wiksell International. Stockholm, pp 197–210
  Google Scholar
• Hugli TE (1983) The chemistry and biology of C3a, C4a and C5a and their effect on cells. John Jacob Abel Symposium, Baltimore, Maryland, June 21–22, 1982. In: August JT (ed) Biological response mediators and modulators. Academic Press, New York, p 99
  Google Scholar
• Hugh TE, Erickson BW (1977) Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin. Proc Natl Acad Sci USA 74: 1826
  PubMed Google Scholar
• Hugh TE, Muller-Eberhard HJ (1978) Anaphylatoxins: C3a and C5a. Adv Immunol 26: 1–53
  PubMed Google Scholar
• Hugli TE, Morgan WT, Muller-Eberhard HJ (1975) Circular dichroism of C3 a anaphylatoxin: effects of pH, heat, guanidinium chloride and mercaptoethanol on conformation and function. J Biol Chem 250:1479
  PubMed Google Scholar
• Hugh TE, Kawahara MS, Unson CG, Molinor RL, Erickson BW (1983) The active site of human C4a anaphylatoxins. Mol Immunol 20: 637
  PubMed Google Scholar
• Hugh TE, Stimler NP, Bloor CM (1983) Immunopharmacology of complement anaphylatoxins in the lung. In: Newhall HH (ed) Immunopharmacology of the lung, Vol. 19. Marcel Dekker, Inc, New York, pp 401–434
  Google Scholar
• Issekutz AC, Movat KW, Movat HZ (1980) Enhanced vascular permeability and haemorrhage-inducing activity of rabbit C5adesArg: probable role of polymorphonuclear leucocyte lysosomes. Clin Exp Immunol 41: 512
  PubMed Google Scholar
• Jacob HS, Craddock RB, Hammerschmidt DE, Moldow CF (1980) Complement-induced granulocyte aggregation. An unsuspected mechanism of disease. N Engl J Med 302: 789
  PubMed Google Scholar
• Jacobs JW, Rubin JS, Hugh TE, Bogardt RA, Mariz IK, Daniels JS, Daughaday WH, Bradshaw RA (1978) Purification, characterization, and amino acid sequence of rat anaphylatoxin (C3a). Biochemistry 17: 5031
  PubMed Google Scholar
• Janoff A, White R, Carp H, Harel S, Dearing R, Lee D (1979) Lung injury induced by leukocytic proteases. Am J Pathol 97: 111
  PubMed Google Scholar
• Johnson AR, Hugli TE, Muller-Eberhard HJ (1975) Release of histamine from mast cells by the complement peptides C3a and C5a. Immunology 28: 1067
  PubMed Google Scholar
• Jose PJ, Forrest MJ, Williams TJ (1981) Human C5adesArg increases vascular permeability. J Immunol 127: 2376
  PubMed Google Scholar
• Kay AB (1970) Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea pig serum by antigen-antibody complexes. Clin Exp Immunol 1: 723
  Google Scholar
• Kay AB, Shin HS, Austin KF (1973) Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). Immunology 24: 969
  PubMed Google Scholar
• Lepow IH, Willms-Kretschmer K, Patrick RA, Rosen FS (1970) Gross and ultrastructural observations of lesions produced by intradermal injection of human C3a in man. Am J Pathol 61: 13
  PubMed Google Scholar
• Lett-Brown MA, Boetcher DA, Leonard EJ (1976) Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor. J Immunol 117: 246
  PubMed Google Scholar
• Lu Z, Fok KF, Erickson BW, Hugh TE (in press) Conformational analysis of COOH-terminal fragments of human C3a: Evidence of ordered conformation in an active monocosapeptide. J Biol Chem
• McCarthy K, Henson PM (1979) Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified fragments C5a and C5ades Arg. J Immunol 123: 2511
  PubMed Google Scholar
• Moon KE, Gorski JP, Hugh TE (1981) Complete primary structure of human C4a anaphylatoxin. J Biol Chem 256: 8685
  PubMed Google Scholar
• O'Flaherty JT, Ward PA (1979) Leukocyte aggregation induced by chemotactic factors. Inflammation 3: 177
  Google Scholar
• O'Flaherty JT, Kreutzer DL, Ward PA (1978) Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes. Am J Pathol 90: 537
  PubMed Google Scholar
• Paques EP, Scholze H, Huber R (1980) Purification and crystallization of human anaphylatoxin C3a. Hoppe Seylers Z Physiol Chem 361: 915
  PubMed Google Scholar
• Plummer HR Jr, Hurwitz NY (1978) Human plasma carboxypeptidase. J Biol Chem 253: 3907
  PubMed Google Scholar
• Regal JF, Pickering RG (1979) The effect of C5a on the isolated guinea pig trachea. Fed Proc 38: 848
  Google Scholar
• Regal JF, Eastman AY, Pickering RJ (1980) C5a-induced tracheal contraction: a histamine independent mechanism. J Immunol 124: 2876
  PubMed Google Scholar
• Schiffman E, Corcoran BA, Wahl SM (1975) N-Formylmethionyl peptides as chemattractants for leukocytes. Proc Natl Acad Sci USA 72: 1059
  PubMed Google Scholar
• Shin HS, Snyderman R, Friedman E, Mellors A, Mayer MM (1968) Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 162: 361
  PubMed Google Scholar
• Smith MA, Gerrie LM, Dunbar B, Fothergill JE (1982) Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Biochem J 207: 253
  PubMed Google Scholar
• Snyderman R, Shin HS, Hausman MH (1971) A chemotactic factor for mononuclear leukocytes. Proc Soc Exp Biol Med 138: 387
  PubMed Google Scholar
• Stimler NP, Brocklehurst WE, Bloor CM, Hugh TE (1980) Complement anaphylatoxin C5a stimulates release of SRS-A-like activity from guinea pig lung fragments. Letter to the Editor. J Pharm Pharmacol 32: 804
  PubMed Google Scholar
• Stimler NP, Hugh TE, Bloor CM (1980) Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol 100: 327
  PubMed Google Scholar
• Stimler NP, Brocklehurst WE, Hugli TE, Bloor CM (1981) Anaphylatoxin-mediated contraction of guinea pig lung strips: a non-histamine tissue response. J Immunol 126: 2258
  PubMed Google Scholar
• Stimler NP, Bach MK, Bloor CM, Hugh TE (1982) Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin. J Immunol 128: 2247
  PubMed Google Scholar
• Stimler NP, Bloor CM, Hugli TE (1983) C3a-induced contraction of guinea pig lung parenchymal: role of cyclooxygenase metabolites. Immunopharmacology 5: 251
  PubMed Google Scholar
• Unson CG, Erickson BW, Hugli TE (in press) Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues. Biochemistry
• Vallota EH, M üler-Eberhard HJ (1973) Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J Exp Med 137: 1109
  PubMed Google Scholar
• Vogt W (1974) Activation, activities and pharmacologically active products of complement. Pharmacol Rev 26: 125
  PubMed Google Scholar
• Ward PA (1967) A plasmin-split fragment of C3 as a new chemotactic factor. J Exp Med 126: 189
  PubMed Google Scholar
• Ward PA (1968) Chemotaxis of mononuclear cells. J Exp Med 128: 1201
  PubMed Google Scholar
• Ward PA (1979) Immune complex injury of the lung. Am J Pathol 97: 85
  PubMed Google Scholar
• Ward PA, Newman LJ (1969) A neutrophil chemotactic factor from human C5. J Immunol 120: 93
  Google Scholar
• Weigle WO, Morgan EL, Goodman MG, Chenoweth DE, Hugh TE (1982) Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cell. Fed Proc 41: 3099
  PubMed Google Scholar
• Weigle WO, Goodman MG, Morgan EL, Hugli TE (1983) Regulation of immune response by components of the complement cascade and their activated fragments. Springer Seminar Immunopathol 6: 173
  Google Scholar
• Wissler JH (1972) Chemistry and biology of the anaphylatoxin related serum peptide system. I. Purification, crystallization and properties ofclassical anaphylatoxin from rat serum. Eur J Immunol 2: 73
  PubMed Google Scholar
• Wuepper RB, Bokisch VA, Müller-Eberhard HJ, Stoughton RB (1972) Cutaneous responses to human C3 anaphylatoxin in man. Clin Exp Immunol 11: 13
  PubMed Google Scholar